Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat.

Roehl AB, Funcke S, Becker MM, Goetzenich A, Bleilevens C, Rossaint R, Steendijk P, Hein M.

Anesthesiology. 2013 Jun;118(6):1385-94. doi: 10.1097/ALN.0b013e31828744c0.

PMID:
23364599
2.

Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.

Lucchinetti E, Jamnicki M, Fischer G, Zaugg M.

Anesth Analg. 2008 Jan;106(1):17-23, table of contents. doi: 10.1213/01.ane.0000289527.70545.ed.

PMID:
18165546
3.

Xenon and isoflurane improved biventricular function during right ventricular ischemia and reperfusion.

Hein M, Roehl AB, Baumert JH, Bleilevens C, Fischer S, Steendijk P, Rossaint R.

Acta Anaesthesiol Scand. 2010 Apr;54(4):470-8. doi: 10.1111/j.1399-6576.2009.02116.x. Epub 2009 Oct 15.

PMID:
19839950
4.

Xenon is not superior to isoflurane on cardiovascular function during experimental acute pulmonary hypertension.

Roehl AB, Steendijk P, Rossaint R, Bleilevens C, Goetzenich A, Hein M.

Acta Anaesthesiol Scand. 2012 Apr;56(4):449-58. doi: 10.1111/j.1399-6576.2011.02624.x. Epub 2012 Jan 19.

PMID:
22260254
5.

Establishment of a porcine right ventricular infarction model for cardioprotective actions of xenon and isoflurane.

Hein M, Roehl AB, Baumert JH, Bantes B, Bleilevens C, Bernstein N, Steendijk P, Rossaint R.

Acta Anaesthesiol Scand. 2008 Oct;52(9):1194-203. doi: 10.1111/j.1399-6576.2008.01757.x.

PMID:
18823457
6.

Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.

Burstein B, Maguy A, Clément R, Gosselin H, Poulin F, Ethier N, Tardif JC, Hébert TE, Calderone A, Nattel S.

J Pharmacol Exp Ther. 2007 Dec;323(3):916-23. Epub 2007 Sep 17.

7.

The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats.

Hu ZY, Luo NF, Liu J.

Can J Anaesth. 2009 Feb;56(2):115-25. doi: 10.1007/s12630-008-9016-3. Epub 2008 Dec 31.

PMID:
19247759
8.
9.

Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.

Yin M, van der Horst IC, van Melle JP, Qian C, van Gilst WH, Silljé HH, de Boer RA.

Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H459-68. doi: 10.1152/ajpheart.00054.2011. Epub 2011 May 13.

10.

Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase B/Akt signaling.

Feng J, Fischer G, Lucchinetti E, Zhu M, Bestmann L, Jegger D, Arras M, Pasch T, Perriard JC, Schaub MC, Zaugg M.

Anesthesiology. 2006 May;104(5):1004-14.

PMID:
16645453
11.

Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation.

Schroth SC, Schotten U, Alkanoglu O, Reyle-Hahn MS, Hanrath P, Rossaint R.

Anesthesiology. 2002 Feb;96(2):422-7.

PMID:
11818777
12.

Cardioprotective effects of anesthetic preconditioning in rats with ischemia-reperfusion injury: propofol versus isoflurane.

Tao X, Lu LQ, Xu Q, Li SR, Lin MT.

J Zhejiang Univ Sci B. 2009 Oct;10(10):740-7. doi: 10.1631/jzus.B0920119.

13.

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.

Liu Q, Anderson C, Broyde A, Polizzi C, Fernandez R, Baron A, Parkes DG.

Cardiovasc Diabetol. 2010 Nov 16;9:76. doi: 10.1186/1475-2840-9-76.

14.

Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo.

Kehl F, Pagel PS, Krolikowski JG, Gu W, Toller W, Warltier DC, Kersten JR.

Anesth Analg. 2002 Nov;95(5):1162-8, table of contents.

PMID:
12401584
15.

Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.

Zeng WT, Chen WY, Leng XY, Tang LL, Sun XT, Li CL, Dai G.

Cardiovasc Ther. 2012 Jun;30(3):152-61. doi: 10.1111/j.1755-5922.2010.00255.x. Epub 2010 Dec 19.

PMID:
21167013
16.

Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2.

Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC.

Anesthesiology. 2004 Mar;100(3):525-31.

PMID:
15108964
17.

Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction.

Ueda S, Yamagishi S, Matsui T, Jinnouchi Y, Imaizumi T.

Am J Pathol. 2011 Feb;178(2):591-8. doi: 10.1016/j.ajpath.2010.10.018.

18.

Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery.

Wappler F, Rossaint R, Baumert J, Scholz J, Tonner PH, van Aken H, Berendes E, Klein J, Gommers D, Hammerle A, Franke A, Hofmann T, Schulte Esch J; Xenon Multicenter Study Research Group.

Anesthesiology. 2007 Mar;106(3):463-71.

PMID:
17325504
19.

The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.

Weber NC, Toma O, Wolter JI, Obal D, Müllenheim J, Preckel B, Schlack W.

Br J Pharmacol. 2005 Jan;144(1):123-32.

20.

Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.

Pantos C, Mourouzis I, Markakis K, Dimopoulos A, Xinaris C, Kokkinos AD, Panagiotou M, Cokkinos DV.

Eur J Cardiothorac Surg. 2007 Aug;32(2):333-9. Epub 2007 Jun 7.

PMID:
17560116
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk